MeSH D012772 - septic shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Epinephrine | Epinephrine |  | 2018-08-16 |  |  |
| Padagis | Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2022-02-11 |  |  | |
| Mylan | Epinephrine | Epi | 2025-09-11 | 1987-12-22 |  |  |
| Perrigo | Ibuprofen, Phenylephrine | Ibuprofen Phenylephrine |  | 2014-07-03 |  |  |
| GSK | Ibuprofen, Phenylephrine, Chlorpheniramine | Advil |  | 2011-12-21 |  |  |
| Armstrong Pharmaceuticals | Epinephrine | Epinephrine |  | 1984-05-23 |  |  |
| Epinephrine | Primatene Mist | 2026-01-26 | 2018-11-07 |  |  | |
| Lupin Research | Phenylephrine, Ketorolac tromethamine | Ketorolac Tromethamine Phenylephrine |  | 2019-07-01 |  |  |
| Sandoz | Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  |
| Phenylephrine | Phenylephrine |  | 2019-01-31 |  |  | |
| Dexamethasone, Ciprofloxacin | Ciprodex | 2025-06-04 | 2003-07-18 |  |  | |
| Dexamethasone, Tobramycin | Tobradex |  | 1988-08-18 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
90%19/21
Phase 2
70%42/60
Phase 3
42%35/84
Approved: 5Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use